Tablets & Capsules

2019 Annual Buyers Guide

Issue link: https://www.e-digitaleditions.com/i/1048238

Contents of this Issue

Navigation

Page 28 of 147

Tablets & Capsules November 2018 23 i n d e x t o a r t i c l e s The 10 most common 483s and how to avoid them. Carol Tousey. October 2010, p. 24. Time to revise CPSC protocol testing. Laura Bix, Javier de la Fuente, and Alaster Yoxall. October 2010, p. 32. Top 10 ways to get an FDA warning letter. Lisa Thomas. April 2014, p. 32C. Track and trace: Options for compliance. Mark Feher. May 2013, p. 12. Update on the FDA's spectral library of excipients. Philip H. Merrell, Lucinda Buhse, and Jason D. Rodriguez. July 2013, p. 27. Updates and harmonization of USP standards. Catherine Sheehan and John A. Giannone. Eye on Excipients, March 2017, p. 47. What standard? Investigation raises questions about DNA testing. Evan Hansen. April 2015, p. 32B. What's in excipients? Janeen Skutnik-Wilkinson. Eye on Excipients, May 2013, p. 31. You can't correct for randomness. Ben Locwin. Back Page, October 2013, p. 48. Roll compaction Benefits of a laser-based system to measure the solid fraction of compacted ribbons and tablets. Terry Chriss. March 2017, p. 41. Density mapping of roller-compacted ribbons using tera- hertz spectroscopy. Mark Sullivan, David Heaps, Richard McKay, Eiji Kato, Xiao Hua Zhou, Chuan-Yu Wu, Chun-lei Pei, Jian-yi Zhang, and Serena Schiano. January 2015, p. 26. Introduction to servo-hydraulic compaction simulators. Jean LeFloch. September 2012, p. 18. Sampling Effect of sampling methods on vitamin D blending unifor- mity. Wenming Zeng, Dan Wang, and Doug Roper. Octo- ber 2016, p. 17. Tips for taking samples from powder blends. Peter Holman. July 2016, p. 39. Sieving and screening Selecting a vibratory sieve to check-screen highly potent powders. Rob O'Connell. October 2013, p. 23. Size reduction How to get better grinding performance with pneumatic conveying. Gary Liu. May 2018, p. 28. Jet Pulverizer adds ISO 8 suite. March 2015, p. 24. Softgels Are softgels right for your product? Tomasz Bokas. Sep- tember 2018, p. 37. Breaking-force tests for empty and filled hard capsules and softgels. Walter Friesendorf. Capsules and Capsule Filling Desktop Reference, July 2010, p. 17. Characterization and modeling of softgel drying processes. Q. Fang, Y. Hu, N. Yu, S. Majuru, and M. Hariharan. May 2011, p. 24. Dissolution of oil-filled softgels: Formulation and analytical development. Claudia Silva, Jose Acosta, and Diego Mon- terroza. May 2017, p. 34. Mutual recognition agreements and other FDA activities for monitoring the US drug product supply chain. James Evans. October 2018, p. 12. NDI Draft Guidance: A year later. Jusin J. Prochnow. July 2012, p. 32C. Navigating the landscape of structure/function statements. Justin J. Prochnow. October 2011, p. 32C. New ADIs and GMPs spell C-H-A-N-G-E. Emily Nystrom. March 2008, p. 18. New developments in dissolution testing of tablets and cap- sules. Margareth R. C. Marques, William Brown, Gabriel Giancaspro, Natalia Davydova, Edith Chang, Jeanne Fringer, Walter Hauck, and Anthony DeStefano. October 2012, p. 12. The new dietary-supplement GMPs: An invitation to sci- ence. Barry Brown. September 2008, p. 32C. A new framework for using new excipients? Matthew Knopp. Eye on Excipients, January 2014, p. 39. New USP elemental impurity testing: Selecting a method. Andrew Fussell. Back Page, March 2015, p. 48. Options for conducting elemental impurities testing. Timo- thy Klock. Back Page, July 2016, p. 48. Pediatric formulations. Alen Guy. Eye on Excipients, April 2013, p. 37. The problem areas in meeting dietary-supplement cGMPs. Joy Joseph. October 2011, p. 26. QbD and co-processed excipients: A low-risk alternative to API-in-capsule for expediting first-in-human studies. Adam Lambert. March 2014, p. 18. A Quality-by-Design comparison of two film coating sys- tems. Brian Cheng. April 2013, p. 12. Quality by Design's impact on the cost of drug develop- ment. Ken Seufert. October 2013, p. 17. Recent challenges in dissolution testing, including USP ini- tiatives. Vivian A. Gray, January 2012, p. 28. Recent developments regarding a Novel Excipient Qualifi- cation process. David R. Schoneker and Nigel Langley. Back Page, July 2017, p. 44. Regulatory compliance: Patients talk. Ben Locwin. Back Page, October 2012, p. 48. The role of the ingredient supplier in cGMP compliance. Rupa Das. January 2009, p. 32C. Safety evaluations of new excipients. Christopher DeMerlis, Elaine V. Knight, R. Christian Moreton, and Robert E. Osterberg. Eye on Excipients, April 2011, p. 39. Serialization: Too late to start? Michael L. Keech. Back Page, May 2017, p. 48. Stability modeling and package selection. Matthew Knopp. May 2016, p. 11. Stability testing. Philip H. Merrell. Eye on Excipients, Octo- ber 2012, p. 33. The supplement industry's latest threat: Class-action law- suits. Justin Prochnow. July 2014, p. 32C. Take color, printing into account when developing capsule products. Cale E. Murray. Back Page, October 2011, p. 64.

Articles in this issue

Archives of this issue

view archives of Tablets & Capsules - 2019 Annual Buyers Guide